Citadel Advisors’s GP-Act III Acquisition Corp GPAT Stock Holding History
Bought
Maintained
Sold
Other funds holding GPAT
PAMP
AA
MI
AIMCA
MSU
WRBC
HIM
Citadel Advisors's GPAT Position: Q2 2026 in Review
Citadel Advisors increased its GP-Act III Acquisition Corp (GPAT) stake by 17% in Q2 2026, buying an estimated $31.1K and bringing the position to 20,039 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #11866.
Citadel Advisors first reported a position in GPAT in Q4 2024 and has held it in 7 quarters since. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.
- Citadel Advisors held 20,039 shares of GP-Act III Acquisition Corp worth $218K as of Q2 2026.
- Citadel Advisors bought 2,867 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $31.1K.
- GP-Act III Acquisition Corp made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11866 holding.
- Citadel Advisors first reported a position in GP-Act III Acquisition Corp in Q4 2024 and has held it in 7 quarters since.
- 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.